Product ID: SQMIG35A2503
Report ID:
SQMIG35A2503 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
92 |
Figures:
76
Global Spirometer Market Drivers
Rising Incidence of respiratory diseases
The escalating incidence of respiratory diseases represents a significant global health challenge, with several such diseases ranking among the top 30 causes of mortality. Notably, chronic obstructive pulmonary disease (COPD) stands as the third leading cause of death worldwide. The timely identification and diagnosis of respiratory ailments hold immense therapeutic value, significantly improving treatment outcomes. Within this context, spirometry emerges as a pivotal technology, aiding in the assessment of disease severity and mitigating the risk of misdiagnosis. Consequently, as the prevalence of respiratory diseases continues to surge, the spirometers market is poised for robust expansion. It's essential to acknowledge that advancing age diminishes the efficiency of vital bodily organs and physiological processes, accentuating the urgency for effective respiratory disease diagnosis and management.
Emerging economies
Growing economies like India, Brazil, China, and South Africa present substantial prospects for participants in the spirometry devices market. It's worth noting that among the top 20 most polluted cities globally, a striking 14 are located in India. Unfortunately, the adoption of spirometers for monitoring lung health remains quite limited in these nations.
Increasing Technological Advancement in Diagnostic Tools to Surge Demand
The demand for lung function tests is steadily increasing as they play a crucial role in assessing the fundamental functioning of the lungs. These tests, collectively known as Pulmonary Function Tests (PFTs), encompass parameters like lung volumes, capacities, flow rates, and gas exchange, providing valuable insights for diagnosing various lung disorders, particularly Chronic Obstructive Pulmonary Disease (COPD). Technological advancements are poised to significantly impact this market, with key industry players making substantial investments in research and development to create novel and advanced diagnostic and monitoring technologies, thereby facilitating the early detection of COPD.
Rising Prevalence of COPD to Propel Product Sales
The increasing prevalence of Chronic Obstructive Pulmonary Disease (COPD) is driving sales of diagnostic devices in response to a significant global health challenge. COPD stands as the third leading cause of death on a global scale and imposes substantial burdens on both patients and healthcare services. As per data from the National Heart, Lung, and Blood Institute, COPD is the primary cause of mortality in the United States, impacting approximately 16 million Americans. The primary risk factor associated with COPD is tobacco smoking, although other environmental factors such as air pollution and exposure to biomass fuels can also contribute to severe health complications. The escalating prevalence of this disorder represents a critical and widespread issue, spurring the demand for diagnostic devices throughout the forecast period.
Global Spirometer Market Restraints
Lack of Awareness and Availability
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35A2503